These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2955628)

  • 21. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
    Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
    J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Resetkova E; Arreanza G; Carayon P; Volpé R
    J Endocrinol Invest; 1993 Sep; 16(8):609-17. PubMed ID: 8258649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UCLA conference. Autoimmune thyroid diseases--Graves' and Hashimoto's.
    Ann Intern Med; 1978 Mar; 88(3):379-91. PubMed ID: 204241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intrathyroidal T cell activation and HLA-DR antigen expression on thyroid follicular cells in autoimmune thyroid diseases].
    Wang J
    Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):77-80, 127. PubMed ID: 1327436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.
    Canonica GW; Caria M; Torre G; Risso A; Cosulich ME; Bagnasco M
    J Endocrinol Invest; 1984 Dec; 7(6):641-5. PubMed ID: 6335716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage-lymphocyte interaction in Graves' disease and Hashimoto's thyroiditis.
    Sugenoya A; Silverberg J; Trokoudes K; Row VV; Volpé R
    Acta Endocrinol (Copenh); 1979 May; 91(1):99-108. PubMed ID: 88154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease.
    Davies TF; Martin A; Concepcion ES; Graves P; Cohen L; Ben-Nun A
    N Engl J Med; 1991 Jul; 325(4):238-44. PubMed ID: 1829139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood lymphocyte transformation to G2s in patients with autoimmune thyroid disease with and without ophthalmopathy.
    Chang CH; Yamada M; Blanchard ME; Li AW; Wall JR
    Autoimmunity; 2002 Aug; 35(5):313-7. PubMed ID: 12515285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of CD4+ (helper/inducer) T lymphocytes in autoimmune thyroid disease: demonstration of specific induction in response to thyroid peroxidase (TPO) in vitro and its relationship with thyroid status in vivo.
    Akasu F; Kasuga Y; Matsubayashi S; Carayon P; Volpé R
    Thyroid; 1991; 1(3):215-22. PubMed ID: 1688100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated interstitial and intraepithelial thyroid lymphocytes in autoimmune thyroid disease.
    Cohen SB; Weetman AP
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):161-6. PubMed ID: 3176812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer.
    Bagnasco M; Caretto A; Olive D; Pedini B; Canonica GW; Betterle C
    Clin Exp Immunol; 1991 Feb; 83(2):309-13. PubMed ID: 1671565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ia+ T cells in new onset Graves' disease.
    Jackson RA; Haynes BF; Burch WM; Shimizu K; Bowring MA; Eisenbarth GS
    J Clin Endocrinol Metab; 1984 Aug; 59(2):187-90. PubMed ID: 6610685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
    Zhang H; Li D; Ouyang A
    Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.
    Fournier C; Chen H; Leger A; Charreire J
    Clin Exp Immunol; 1983 Nov; 54(2):539-46. PubMed ID: 6228354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
    Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
    Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
    Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
    J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.